151 related articles for article (PubMed ID: 15643804)
1. Rebuilding the ship as we sail: knowledge management in antiretroviral treatment scale-up.
Bailey C
Bull World Health Organ; 2004 Oct; 82(10):798-800. PubMed ID: 15643804
[No Abstract] [Full Text] [Related]
2. Continued correspondence 'Will ART rollout in Africa drive an epidemic of drug-resistant HIV?'.
Hastings IM; Lalloo DG; Khoo SH
AIDS; 2007 Jan; 21(2):258-9; author reply 259-60. PubMed ID: 17197825
[No Abstract] [Full Text] [Related]
3. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
[TBL] [Abstract][Full Text] [Related]
4. The real challenges for scaling up ART in sub-Saharan Africa.
Van Damme W; Kober K; Laga M
AIDS; 2006 Mar; 20(5):653-6. PubMed ID: 16514294
[No Abstract] [Full Text] [Related]
5. Estimating the number of antiretroviral treatment facilities based on the Wilson-Blower method.
Malangu N
PLoS Med; 2005 Aug; 2(8):e270. PubMed ID: 16120012
[No Abstract] [Full Text] [Related]
6. Computerised information management systems in HIV/AIDS care and outcomes research.
Simbini T
Cent Afr J Med; 2006; 52(5-6):65-7. PubMed ID: 18254459
[TBL] [Abstract][Full Text] [Related]
7. Antiretroviral treatment: current approach and future prospects.
Taiwo BO
Afr J Med Med Sci; 2006 Dec; 35 Suppl():1-11. PubMed ID: 18050771
[TBL] [Abstract][Full Text] [Related]
8. Family planning choices for women with HIV.
Richey C; Setty V
Popul Rep L; 2007 Aug; (15):1, 3-23. PubMed ID: 17974162
[No Abstract] [Full Text] [Related]
9. WHO puts HIV/AIDS pandemic at top of its agenda.
Zarocostas J
Lancet; 2004 May; 363(9421):1615. PubMed ID: 15146891
[No Abstract] [Full Text] [Related]
10. Who will bridge the HIV treatment-prevention gap?
Weis P; Schmid G; De Cock K
J Infect Dis; 2008 Jul; 198(2):293-4. PubMed ID: 18593296
[No Abstract] [Full Text] [Related]
11. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.
Bennett DE; Bertagnolio S; Sutherland D; Gilks CF
Antivir Ther; 2008; 13 Suppl 2():1-13. PubMed ID: 18578063
[TBL] [Abstract][Full Text] [Related]
12. HIV/AIDS in Papua New Guinea: an unfolding disaster?
McBride WJ
Emerg Med Australas; 2005 Aug; 17(4):304-6. PubMed ID: 16091091
[No Abstract] [Full Text] [Related]
13. Early warning indicators for HIV drug resistance in Malawi.
Hedt BL; Wadonda-Kabondo N; Makombe S; Harries AD; Schouten EJ; Limbambala E; Hochgesang M; Aberle-Grosse J; Kamoto K
Antivir Ther; 2008; 13 Suppl 2():69-75. PubMed ID: 18575193
[TBL] [Abstract][Full Text] [Related]
14. The "free by 5" campaign for universal, free antiretroviral therapy.
Whiteside A; Lee S
PLoS Med; 2005 Aug; 2(8):e227. PubMed ID: 16008506
[TBL] [Abstract][Full Text] [Related]
15. HIV/AIDS in 2004: the epidemiologist's point of view.
Girardi E; Lauria FN; Ippolito G
Cell Death Differ; 2005 Aug; 12 Suppl 1():837-44. PubMed ID: 15776000
[No Abstract] [Full Text] [Related]
16. Combining evidence for access to and benefits from antiretroviral treatment to inform planning.
; Marlink R; Forsythe S; Bertozzi SM; Muirhead D; Holmes M; Sturchio J
AIDS; 2008 Jul; 22 Suppl 1():S121-2. PubMed ID: 18664943
[No Abstract] [Full Text] [Related]
17. Surveillance of transmitted HIV drug resistance with the World Health Organization threshold survey method in Lilongwe, Malawi.
Kamoto K; Aberle-Grasse J;
Antivir Ther; 2008; 13 Suppl 2():83-7. PubMed ID: 18575195
[TBL] [Abstract][Full Text] [Related]
18. Reconsidering the impact of conflict on HIV infection among women in the era of antiretroviral treatment scale-up in sub-Saharan Africa: a gender lens.
Shannon K; Kaida A; Rachlis B; Lloyd-Smith E; Gray G; Strathdee SA
AIDS; 2008 Sep; 22(14):1705-7. PubMed ID: 18753938
[No Abstract] [Full Text] [Related]
19. Implementing early-warning indicators of HIV drug resistance in the Caribbean.
Jack N; Ravasi G; Schrooten W; Sutherland D; Ghidinelli M; Del Riego A
Clin Infect Dis; 2012 May; 54 Suppl 4():S290-3. PubMed ID: 22544189
[TBL] [Abstract][Full Text] [Related]
20. Sudan and Djibouti are the first ERM beneficiaries from HIV/AIDS treatment initiative.
Ann Saudi Med; 2004; 24(2):151. PubMed ID: 15323282
[No Abstract] [Full Text] [Related]
[Next] [New Search]
